Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Cartier-Lacave

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Human Gene Therapy Methods|August 17, 2016
Debate on Germline Gene EditingNathalie Cartier-Lacave, Robin Ali, Seppo Ylä-Herttuala, et al.
Human Gene Therapy. Clinical Development|March 12, 2015
Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman PrimatesMichel Zerah, Françoise Piguet, Marie-Anne Colle, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Human Gene Therapy Methods|August 17, 2016
Debate on Germline Gene EditingNathalie Cartier-Lacave, Robin Ali, Seppo Ylä-Herttuala, et al.
Human Gene Therapy. Clinical Development|March 12, 2015
Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman PrimatesMichel Zerah, Françoise Piguet, Marie-Anne Colle, et al.
Pageof 1